ClinicalThought

Share

Program Content

  • Sacituzumab Govitecan in TNBC
    A 44-Year-Old Patient With Rapidly Progressing Metastatic TNBC Who Receives Sacituzumab Govitecan
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 14, 2022

    Expires: November 13, 2023

    View Activity
  • FAQs: Optimal Tx of TNBC
    FAQs: Optimizing Management of Patients with Triple-Negative Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 14, 2023

    Expires: March 12, 2024

    View Activity

Faculty

cover img faculity

Mark Pegram,

Professor
Medical Oncology
Stanford University
Palo Alto, California

cover img faculity

Laura M. Spring, MD

Assistant Professor of Medicine
Harvard Medical School
Attending Physician, Medical Oncology (Breast Program)
Massachusetts General Hospital
Boston, Massachusetts

cover img faculity

Sara M. Tolaney, MD, MPH

Assistant Professor of Medicine
Harvard Medical School
Associate Director
Susan F. Smith Center for Women’s Cancers
Director
Clinical Trials, Breast Oncology
Director
Breast Immunotherapy Clinical Research
Dana-Farber Cancer Institute
Boston, Massachusetts

Provided by

ProCE Banner

Supporters

Gilead Sciences, Inc.

Partners

Smart Patients

ProCE Banner